CD36 haplotypes are associated with lipid profile in normal-weight subjects

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Ramos Arellano, Luz E ^a   Salgado Bernabé, Aralia B ^a   Guzmán Guzmán, Iris P ^a   Salgado Goytia, Lorenzo ^a   Muñoz Valle, José F ^b   Parra Rojas, Isela ^a  

^a UNIVERSIDAD AUTÓNOMA DE GUERRERO   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

CD36 gene; Dyslipidemia; Haplotypes; Polymorphisms

Indexed keywords

CD36 ANTIGEN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; COLORIMETRY; DNA POLYMORPHISM; DYSLIPIDEMIA; ENZYMATIC ASSAY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HUMAN; LIPID ANALYSIS; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; ANTIGENS, CD36; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HAPLOTYPES; HEALTHY VOLUNTEERS; HUMANS; LINKAGE DISEQUILIBRIUM; LIPOPROTEINS, LDL; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; SEX FACTORS; TRIGLYCERIDES;

EID: 84887105677     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-167     Document Type: Article

References (37)

1. Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels. Yin RX, Li YY, Lai CQ, Lipids Health Dis 2011 10 140 10.1186/1476-511X-10-140 21854571
2. Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery. Wasan KM, Brocks DR, Lee SD, Barrable KS, Thornton SJ, Nat Rev Drug Discov 2008 7 84 97 10.1038/nrd2353 18079757
3. Familial Dyslipidaemias: an Overview of Genetics, Pathophysiology and Management. Hachem SB, Mooradian AD, Drugs 2006 66 15 1949 1969 10.2165/00003495-200666150-00005 17100406 (Pubitemid 44771933)
4. APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population. Alvim RO, Freitas SR, Ferreira NE, Santos PC, Cunha RS, Mill JG, Krieger JE, Pereira AC, Lipids Health Dis 2010 9 128 10.1186/1476-511X-9-128 21059196
5. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation 2002 106 25 3143 3421 12485966
6. The macrophage Ox-LDL receptor, CD36 and its association with type II diabetes mellitus. Gautam S, Banerjee M, Mol Genet Metab 2011 102 389 398 10.1016/j.ymgme.2010.12.012 21262584
7. A specific CD36-dependent signaling pathway is required for platelet activation by oxLDL. Chen K, Frebbraio M, Li W, Silverstein RL, Cir Res 2008 102 12 1512 1519 10.1161/CIRCRESAHA.108.172064
8. Mapping and characterization of the binding site for specific oxidized phospholipids and oxidized low density lipoprotein of scavenger receptor CD36. Kar NS, Ashraf MZ, Valiyaveettil M, Podrez EA, J Biol Chem 2008 283 13 8765 8771 10.1074/jbc.M709195200 18245080
9. Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile. Love-Gregory L, Sherva R, Schappe T, Qi JS, McCrea J, Klein S, Connelly MA, Abumrad NA, Hum Mol Genet 2011 20 1 193 201 10.1093/hmg/ddq449 20935172
10. Positive association of common variants in CD36 with neovascular agerelated macular degeneration. Kondo N, Honda S, Kuno S, Negi A, Aging 2009 1 2 266 274 20157514
11. CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. Drover VA, Ajmal M, Nassir F, Davidson NO, Nauli AM, Sahoo D, Tso P, Abumrad NA, J Clin Invest 2005 115 1290 1297 15841205 (Pubitemid 40629048)
12. Single-nucleotide polymorphism of CD36 locus and obesity in European adolescents. Bokor S, Legry V, Meirhaeghe A, Ruiz JR, Mauro B, Widhalm K, Manios Y, Amouyel P, Moreno LA, Molnàr D, Dallongeville J, HELENA Study group, Obesity 2010 18 7 1398 1403 10.1038/oby.2009.412 19893500
13. Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients. Yamashita S, Hirano K, Kuwasako T, Janabi M, Toyama Y, Ishigami M, Sakai N, Mol Cell Biochem 2007 299 19 22 10.1007/s11010-005-9031-4 16670819 (Pubitemid 46767534)
14. Variants of the CD36 Gene and metabolic syndrome in Boston Puerto Rican adults. Noel SE, Lai C, Mattei J, Parnell LD, Ordovas JM, Tucker KL, Atherosclerosis 2010 211 1 210 215 10.1016/j.atherosclerosis.2010.02.009 20223461
15. CD36 Inhibitors reduce postprandial hypertriglyceridemia and protect against diabetic dyslipidemia and atherosclerosis. Geloen A, Helin L, Geeraert B, Malaud E, Holvoet P, Marguerie G, PLoS ONE 2012 7 5 37633 10.1371/journal.pone.0037633 10.1371/journal.pone.0037633 22662181
16. Molecular basis of human gene mutations. Rac ME, Safranow K, Poncyljusz W, Mol Med 2007 13 5-6 288 296 17673938 (Pubitemid 47175038)
17. Association of CD36 gene variants rs1761667 (G > A) and rs1527483 (C > T) with Type 2 diabetes in North Indian population. Banerjee M, Gautam S, Saxena M, Kumar H, Agrawal C, Int J Diab Mellitus 2010 12 3 179 183 doi:10.1016/j.ijdm.2010.08.002
18. Molecular genetics of experimental hypertension and the metabolic syndrome: from gene pathways to new therapies. Pravenec M, Kurtz TW, Hypertension 2007 49 941 952 10.1161/HYPERTENSIONAHA.107.086900 17339535 (Pubitemid 351688338)
19. Raising HDL cholesterol in women. Eapen DJ, Kalra GL, Rifai L, Eapen CA, Merchant N, Khan BV, Int J Womens Health 2010 1 181 191 21072287
20. Hormones, genetic factors, and gender differences in cardiovascular disease. Rossouw JE, Cardiovasc Res 2002 53 3 550 557 10.1016/S0008-6363(01) 00478-3 11861025 (Pubitemid 34175247)
21. Gender differences in the lipid profile of dyslipidemic subjects. Kolovou GD, Anagnostopoulou KK, Damaskos DS, Bilianou HI, Mihas C, Milionis HJ, Kostakou PM, Cokkinos DV, Eur J Intern Med 2009 20 2 145 151 10.1016/j.ejim.2008.06.011 19327602
22. Lipid profile of type 2 diabetic patients at a rural tertiary hospital in Nigeria. Jimoh K, Adediran S, Agboola M, Busari A, Idowu A, Adeoye A, Adebisi A, J Diabetes Endocrinol 2012 1 4 46 51
23. Sex differences in lipid profiles in relation to the progression of glucose abnormalities. Carnevale GP, Fra GP, Colli E, Bigliocca M, Mella R, Scaglia E, Bartoli E, J Diabetes 2012 4 95 101 10.1111/j.1753-0407.2011.00160.x 21951548
24. Greater oxidative stress in healthy young men compared with premenopausal women. Ide T, Tsutsui H, Ohashi N, Hayashidani S, Suematsu N, Tsuchihashi M, Tamai H, Takeshita A, Arterioscler Thromb Vasc Biol 2002 22 3 438 442 10.1161/hq0302.104515 11884287 (Pubitemid 34218751)
25. Adipokines, Oxidized Low-Density Lipoprotein, and C-Reactive Protein Levels in Lean, Overweight, and Obese Portuguese Patients with Type 2 Diabetes. João M, Brandão J, Santos A, Coimbra S, ISRN Obes 2013 142097 7 doi:10.1155/2013/142097
26. Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms. Ghosh A, Murugesan G, Chen K, Zhang L, Wang Q, Febbraio M, Blood 2011 117 23 6355 6366 10.1182/blood-2011-02-338582 21478428
27. Common sequence variants in CD36 gene and the levels of triglyceride and high-density lipoprotein cholesterol among ethnic Chinese in Taiwan. Chien KL, Hsu HC, Liu PH, Lin HJ, Chen MF, Lipids Health Dis 2012 11 174 10.1186/1476-511X-11-174 23249574
28. A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans. Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, O'Connell P, Stern MP, Am J Hum Genet 2000 66 4 1237 1245 10.1086/302849 10729112 (Pubitemid 30468781)
29. Factors of insulin resistance syndrome-related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans. Arya R, Blangero J, Williams K, Almasy L, Dyer TD, Leach RJ, O'Connell P, Stern MP, Duggirala R, Diabetes 2002 51 3 841 847 10.2337/diabetes.51.3.841 11872689 (Pubitemid 34760198)
30. Meta-analysis of genome-wide linkage studies of quantitative lipid traits in families ascertained for type 2 diabetes. Malhotra A, Elbein SC, Ng MC, Duggirala R, Arya R, Imperatore G, Adeyemo A, Pollin TI, Hsueh WC, Chan JC, Rotimi C, Hanson RL, Hasstedt SJ, Wolford JK, Diabetes 2007 56 3 890 896 10.2337/db06-1057 17327462 (Pubitemid 46348475)
31. Insulin sensitivity and lipid metabolism in human CD36 deficiency. Furuhashi M, Ura N, Nakata T, Shimamoto K, Diabetes Care 2003 26 2 471 474 10.2337/diacare.26.2.471 12547883 (Pubitemid 36929076)
32. A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Ma X, Bacci S, Mlynarski W, Gottardo L, Soccio T, Menzaghi C, Iori E, Lager RA, Shroff AR, Gervino EV, Nesto RW, Johnstone MT, Abumrad NA, Avogaro A, Trischitta V, Doria A, Hum Mol Genet 2004 13 9 2197 2205 15282206 (Pubitemid 39359920)
33. CD36 gene promoter polymorphisms are associated with low density lipoprotein-cholesterol in normal twins and after a low-calorie diet in obese subjects. Goyenechea E, Collins LJ, Parra D, Liu G, Snieder H, Swaminathan R, Spector TD, Martínez JA, O'Dell SD, Twin Res Hum Genet 2008 11 6 621 628 10.1375/twin.11.6.621 19016618
34. A genomewide admixture map for Latino populations. Silva I, Price AL, Patterson N, Yu F, Cox DR, Waliszewska A, McDonald GJ, Tandon A, Schirmer C, Neubauer J, Bedoya G, Duque C, Villegas A, Bortolini MC, Salzano FM, Gallo C, Mazzotti G, Tello-Ruiz M, Riba L, Aguilar-Salinas CA, Canizales-Quinteros S, Menjivar M, Klitz W, Henderson B, Haiman CA, Winkler C, Tusie-Luna T, Ruiz-Linares A, Reich D, Am J Hum Genet 2007 80 6 1024 1036 10.1086/518313 17503322 (Pubitemid 47579340)
35. The fatty acid translocase gene CD36 and lingual lipase influence oral sensitivity to fat in obese subjects. Pepino MY, Love-Gregory L, Klein S, Abumrad NA, J Lipid Res 2012 53 3 561 566 10.1194/jlr.M021873 22210925
36. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999 17 2 151 183 10067786
37. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Shi YY, He L, Cell Res 2005 15 97 98 10.1038/sj.cr.7290272 15740637 (Pubitemid 41653949)